These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1314334

  • 21. Current methods of therapy in multiple sclerosis.
    Sibley WA.
    Mod Treat; 1970 Sep; 7(5):918-29. PubMed ID: 4326377
    [No Abstract] [Full Text] [Related]

  • 22. [The problem and value of therapy in multiple sclerosis].
    Hitzschke B, Meyer-Rienecker HJ, Buddenhagen F, Richter M.
    Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
    [Abstract] [Full Text] [Related]

  • 23. [Goodpasture syndrome. Progress in immunopathogenesis, diagnosis and therapy].
    Weber M, Marx M, Merkel F.
    Internist (Berl); 1995 Mar; 36(3):227-35. PubMed ID: 7737815
    [No Abstract] [Full Text] [Related]

  • 24. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A, Fornádi L, Vájlok M.
    Orv Hetil; 1988 Jan 17; 129(3):119-23. PubMed ID: 3281091
    [No Abstract] [Full Text] [Related]

  • 25. [Use of high dose chemotherapy with autologous peripheral hemopoietic cell transplantation in multiple sclerosis].
    Kliuzhev VM, Kovalenko PA, Rukavitsyn OA, Shamanskiĭ SV, Baziĭ NI, Ian'shina IL.
    Voen Med Zh; 2002 Aug 17; 323(8):41-3. PubMed ID: 12379029
    [No Abstract] [Full Text] [Related]

  • 26. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R.
    Neurology; 1988 Jul 17; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [Abstract] [Full Text] [Related]

  • 27. Childhood multiple sclerosis treated with plasmapheresis.
    Takahashi I, Sawaishi Y, Takeda O, Enoki M, Takada G.
    Pediatr Neurol; 1997 Jul 17; 17(1):83-7. PubMed ID: 9308985
    [Abstract] [Full Text] [Related]

  • 28. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 29. [Combined therapy in multiple sclerosis].
    García-Merino JA, Blasco-Quítez MR, Ortiz-Benítez P, Puerta C.
    Rev Neurol; 1972 Feb 29; 36(6):545-9. PubMed ID: 12652419
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Therapeutic plasmapheresis in multiple sclerosis (preliminary report)].
    Bokonjić R, Kantardzić D, Haracić M.
    Neurologija; 1984 Feb 29; 32(1-2):3-11. PubMed ID: 6472573
    [No Abstract] [Full Text] [Related]

  • 33. [Use of therapeutic plasmapheresis in the exacerbation period of multiple sclerosis].
    Neretin VIa, Kir'iakova VA, Sapfirova VA, Ivanov MI, Volkova EK.
    Sov Med; 1988 Feb 29; (2):86-9. PubMed ID: 3388103
    [No Abstract] [Full Text] [Related]

  • 34. Plasmapheresis in multiple sclerosis.
    McLeod BC.
    J Clin Apher; 2003 Feb 29; 18(2):72-4. PubMed ID: 12874820
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasma exchange for MS.
    Noseworthy JH, Vandervoort MK, Ebers GC.
    Neurology; 1990 May 29; 40(5):864-6. PubMed ID: 2158638
    [No Abstract] [Full Text] [Related]

  • 37. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B, Himmerich H, Wellek A, Oertel WH, Sommer N.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():51-5. PubMed ID: 17724968
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Intensive immunosuppression in multiple sclerosis.
    Zaffaroni M, Ghezzi A, Comi G.
    Neurol Sci; 2006 Mar 21; 27 Suppl 1():S13-7. PubMed ID: 16708175
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.